235 related articles for article (PubMed ID: 24612456)
1. Predictors for detection of cancer in patients with indeterminate biliary stricture and atypical cells on endoscopic retrograde brush cytology.
Navaneethan U; Singh T; Gutierrez NG; Jegadeesan R; Venkatesh PG; Brainard J; Vargo JJ; Parsi MA
J Dig Dis; 2014 May; 15(5):268-75. PubMed ID: 24612456
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic cytology in biliary strictures. Personal experience.
Geraci G; Pisello F; Arnone E; Modica G; Sciumè C
G Chir; 2008 Oct; 29(10):403-6. PubMed ID: 18947461
[TBL] [Abstract][Full Text] [Related]
3. Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy.
Barr Fritcher EG; Voss JS; Jenkins SM; Lingineni RK; Clayton AC; Roberts LR; Halling KC; Talwalkar JA; Gores GJ; Kipp BR
Cancer Cytopathol; 2013 Dec; 121(12):708-17. PubMed ID: 23839915
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
[TBL] [Abstract][Full Text] [Related]
5. Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.
Boyd S; Mustonen H; Tenca A; Jokelainen K; Arola J; Färkkilä MA
Scand J Gastroenterol; 2017 Feb; 52(2):242-249. PubMed ID: 27806633
[TBL] [Abstract][Full Text] [Related]
6. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
Boyd S; Vannas M; Jokelainen K; Isoniemi H; Mäkisalo H; Färkkilä MA; Arola J
World J Gastroenterol; 2017 Sep; 23(33):6147-6154. PubMed ID: 28970730
[TBL] [Abstract][Full Text] [Related]
7. Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET.
Sangfelt P; Sundin A; Wanders A; Rasmussen I; Karlson BM; Bergquist A; Rorsman F
J Hepatol; 2014 Dec; 61(6):1352-7. PubMed ID: 25111173
[TBL] [Abstract][Full Text] [Related]
8. Brush cytology during ERCP for the diagnosis of biliary and pancreatic malignancies.
Ferrari Júnior AP; Lichtenstein DR; Slivka A; Chang C; Carr-Locke DL
Gastrointest Endosc; 1994; 40(2 Pt 1):140-5. PubMed ID: 8013810
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of conventional and cholangioscopy-guided sampling of indeterminate biliary lesions at the time of ERCP: a prospective, long-term follow-up study.
Draganov PV; Chauhan S; Wagh MS; Gupte AR; Lin T; Hou W; Forsmark CE
Gastrointest Endosc; 2012 Feb; 75(2):347-53. PubMed ID: 22248602
[TBL] [Abstract][Full Text] [Related]
10. Triple-tissue sampling during endoscopic retrograde cholangiopancreatography increases the overall diagnostic sensitivity for cholangiocarcinoma.
Lee SJ; Lee YS; Lee MG; Lee SH; Shin E; Hwang JH
Gut Liver; 2014 Nov; 8(6):669-73. PubMed ID: 25368755
[TBL] [Abstract][Full Text] [Related]
11. Optimizing the detection of biliary dysplasia in primary sclerosing cholangitis before liver transplantation.
Majeed A; Castedal M; Arnelo U; Söderdahl G; Bergquist A; Said K
Scand J Gastroenterol; 2018 Jan; 53(1):56-63. PubMed ID: 28990806
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic retrograde cholangiopancreatography for cholangiocarcinoma.
Baron TH
Clin Liver Dis; 2014 Nov; 18(4):891-7. PubMed ID: 25438289
[TBL] [Abstract][Full Text] [Related]
13. Role of fluorescence in situ hybridization in diagnosing cholangiocarcinoma in indeterminate biliary strictures.
Liew ZH; Loh TJ; Lim TKH; Lim TH; Khor CJL; Mesenas SJ; Kong CSC; Ong WC; Tan DMY
J Gastroenterol Hepatol; 2018 Jan; 33(1):315-319. PubMed ID: 28543841
[TBL] [Abstract][Full Text] [Related]
14. Investigation of Factors Affecting the Sensitivity of Bile Duct Brush Cytology.
Kobayashi M; Ryozawa S; Araki R; Nagata K; Tanisaka Y; Fujita A; Kobatake T
Intern Med; 2019 Feb; 58(3):329-335. PubMed ID: 30146607
[TBL] [Abstract][Full Text] [Related]
15. Biliary brush cytology and the detection of cholangiocarcinoma in primary sclerosing cholangitis: evaluation of specific cytomorphologic features and CA19-9 levels.
Furmanczyk PS; Grieco VS; Agoff SN
Am J Clin Pathol; 2005 Sep; 124(3):355-60. PubMed ID: 16191503
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic retrograde cholangiopancreatography for primary sclerosing cholangitis.
Thosani N; Banerjee S
Clin Liver Dis; 2014 Nov; 18(4):899-911. PubMed ID: 25438290
[TBL] [Abstract][Full Text] [Related]
17. Impact of trimodality sampling on detection of malignant biliary strictures compared with patients with primary sclerosing cholangitis.
Baroud S; Sahakian AJ; Sawas T; Storm AC; Martin JA; Abu Dayyeh BK; Topazian MD; Levy MJ; Roberts LR; Gores GJ; Petersen BT; Chandrasekhara V
Gastrointest Endosc; 2022 May; 95(5):884-892. PubMed ID: 34871554
[TBL] [Abstract][Full Text] [Related]
18. Transpapillary biliary biopsy for malignant biliary strictures: comparison between cholangiocarcinoma and pancreatic cancer.
Chen WM; Wei KL; Chen YS; Chang PJ; Tung SY; Chang TS; Huang HC; Shen CH; Hsieh YY; Wu CS
World J Surg Oncol; 2016 May; 14():140. PubMed ID: 27142076
[TBL] [Abstract][Full Text] [Related]
19. An animal model of benign bile-duct stricture, sclerosing cholangitis and cholangiocarcinoma and the role of epidermal growth factor receptor in ductal proliferation.
Cheifetz RE; Davis NL; Owen DA
Can J Surg; 1996 Jun; 39(3):193-7. PubMed ID: 8640617
[TBL] [Abstract][Full Text] [Related]
20. Probe-based confocal laser endomicroscopy in the evaluation of dominant strictures in patients with primary sclerosing cholangitis: results of a U.S. multicenter prospective trial.
Han S; Kahaleh M; Sharaiha RZ; Tarnasky PR; Kedia P; Slivka A; Chennat JS; Joshi V; Sejpal DV; Sethi A; Shah RJ
Gastrointest Endosc; 2021 Sep; 94(3):569-576.e1. PubMed ID: 33798541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
